期刊文献+

前列腺癌的分子影像学进展 被引量:5

Progresses in molecular imaging of prostate cancer
暂未订购
导出
摘要 前列腺癌是严重威胁男性健康的疾病。分子影像学的出现,从一个全新角度为前列腺癌的早期诊断与治疗提供了可能,新的前列腺癌标志物也不断出现。本文对当前分子影像学技术,包括核素显像、MRI、超声和光学技术在前列腺癌诊治中的应用进展进行回顾。 Prostate cancer is a serious threat to male health, and the development of molecular imaging provides the possibility for early diagnosis and treatment of prostate cancer from a new perspective. With the emerging markers of prostate cancer, the current modalities of molecular imaging, including radionuclide imaging, MRI, ultrasound and optical imaging in diagnosis and treatment of prostate cancer were reviewed in this article.
出处 《中国医学影像技术》 CSCD 北大核心 2013年第1期150-153,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金(30970830) 重庆市科委自然科学基金(cstc2012jjB10072)
关键词 分子影像学 前列腺肿瘤 磁共振成像 Molecular imaging Prostate neoplasms Magnetic resonance imaging
  • 相关文献

参考文献23

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, 2009,62(1) : 10-29.
  • 2Weissleder R. Molecular imaging: Exploring the next frontier. Radiology, 1999,212 (3) : 609-614.
  • 3You J, Cozzi P, Walsh B, et al. Innovative biomarkers for prostate cancer early diagnosis and progression. Crit Rev Oncol Hematol, 2010,73(1) : 10-22.
  • 4王荣福.分子影像学与分子核医学应用研究现状与进展.中国医学影像技术,2010,26(增刊):220.
  • 5Cooper CR, Chay CH, Pienta KJ. The role of alpha(v)heta(3) in prostate cancer progression. Neoplasia, 2002,4(3):191-194.
  • 6Liu Z, Li ZB, Cao Q, et al. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer. J Nuel Med, 2009, 50(7) : 1168-1177.
  • 7Emonds KM, Swinnen JV, Mortelmans L, et al. Molecular imaging of prostate cancer. Methods, 2009,48(2):193-199.
  • 8Wei L, Li S, Yang J, et al. Protein-based MRI contrast agents for molecular imaging of prostate cancer. Mol Imaging Biol, 2011,13(3) :416-423.
  • 9Heesakkers RA, Hovels AM, Jager GJ, et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lyraph-node dissection in patients with prostate cancer: A prospective multicohort study. Lancet Oncol, 2008, 9 (9) : 850- 856.
  • 10Pinker K, Stadlbauer A, Bogner W, et al. Molecular imaging of cancer: MR spectroscopy and beyond. Eur J Radiol, 2012, 81 (3):566-577.

二级参考文献25

  • 1蒋星军,任彩萍.分子成像及其应用[J].生命科学,2005,17(5):456-460. 被引量:8
  • 2王锡臻,张强,王滨.前列腺癌分子影像学研究进展[J].中国医学影像技术,2005,21(12):1941-1944. 被引量:3
  • 3McLaughlin W, Vizard D. Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals. Nature Methods Application Notes, 2006:26-28.
  • 4Cassidy PJ, Radda GK. Molecular imaging perspectives. J R Soc Interface, 2005,2(3) : 133-144.
  • 5Kumar S, Richards-Kortum R. Optical molecular imaging agents for cancer diagnostics and therapeutics. Nanomedicine, 2006, 1 (1) :23-30.
  • 6Beuthan J. Optical molecular imaging overview and technological aspects. Medical Laser Application, 2002,17(1) :25-30.
  • 7Michael Olive D. Near infrared technology and optical agents for molecular imaging. Biosciences, 2006.
  • 8Konig K, So PTC, Mantulin WW, et al. Two-photon excited lifetime imaging of autofluoreseenee in cells during UVA and NIR photo stress. J Microsc, 1996,183(Pt 3):197-204.
  • 9Frangioni JV. In vivo near infrared fluorescence imaging. Current Opinion in Chemical Biology, 2003,7(5):626-634.
  • 10Grosenick H, Wabnitz H, Rinneberg H, et al. Development of a time domain optical mammography and first in vivo applications. Appl Opt, 1999,38(13) :2927-2943.

共引文献6

同被引文献56

  • 1任静,杨勇,王芳,魏光全,张瑞,杨安钢,宦怡.PSCA特异性MR分子探针的构建及其免疫活性检测[J].国际医学放射学杂志,2011,34(1):4-8. 被引量:2
  • 2李亚军,白人驹,高硕.PET在前列腺癌中的应用[J].国际放射医学核医学杂志,2006,30(5):283-286. 被引量:3
  • 3Jiang J, Chen Y, Zhu Y. Contrast-enhanced ultrasonography forthe detection and characterization of prostate cancer: Correlationwith microvessel density and Gleason score. Clin Radiol, 2011,66(8):732-737.
  • 4Matsumoto K, Nakagawa K, Hashiguchi A, et al. Contrast-en-hanced ultrasonography of the prostate with Sonazoid. Jpn J ClinOncol, 2010,40(11):1099-1104.
  • 5Strazdina A, Krumina G, Sperga M. The value and limitations ofcontrast-enhanced ultrasound in detection of prostate cancer. An-ticancer Res, 2011,31(4):1421-1426.
  • 6Zhu Y, Chen Y, Jiang J, et al. Contrast-enhanced harmonic ul-trasonography for the assessment of prostate cancer aggressive-ness: A preliminary study. Korean J Radiol, 2010,11(1) :75-83.
  • 7Tang J, Yang JC, Luo Y, et al. Enhancement characteristics ofbenign and malignant focal peripheral nodules in the peripheralzone of the prostate gland studied using contrast-enhanced tran-srectal ultrasound. Clin Radiol, 2008, 63(10) : 1086-1091.
  • 8Hodge KK, McNeal JE, Terris MK, et al. Random systematicversus directed ultrasound guided transrectal core biopsies of theprostate. J Urol, 1989,142(1) :71-74.
  • 9Shakil J, Piracha N, Prasad N, et al. Use of outpatient paren-teral antimicrobial therapy for transrectal ultrasound-guidedprostate biopsy prophylaxis in the Setting of community-associ-ated multidrug-resistan escherichia coli rectal colonization. Urol-ogy, 2014,83(4):710-713.
  • 10Haas GP, Delongchamps N, Brawley OW, et al. The world-wide epidemiology of prostate cancer: Perspectives from autopsystudies. Canad J Urol, 2008,15(1) :3866-3871.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部